Blocknomi
Key Highlights Incyte shares decreased 0.78% to close at $98.22 following Japanese regulatory approval. Japanese authorities authorized Minjuvi combined with lenalidomide for relapsed DLBCL treatment. L-MIND clinical trial demonstrated 58.8%…
Related articles
-
US gaming industry groups urge Senate to ban sports prediction markets in crypto bill: report
The Block Published 17.06.2026 04:19
-
GMATRIXS and Plum Protocol Partner to Blend GameFi with Meme Assets, Driving Multi-Chain Web3 User Experience
BlockchainReporter Published 16.06.2026 09:30
-
Alibaba Is Building Qwen-Robot: The Operating System for the Robot Economy
Decrypt Published 16.06.2026 22:32
-
General Motors (GM) Stock Slides 3.8% Following Sodium-Ion Battery Partnership Reveal
Blocknomi Published 10.06.2026 18:37
-
Gary Gensler Backs States in Fight Over Prediction Market Regulation
Decrypt Published 12.06.2026 11:02
-
SanDisk (SNDK) Stock Soars 11% as Apple CEO Confirms Memory Price Crisis is Here to Stay
Blocknomi Published 18.06.2026 15:43
-
What the Strait of Hormuz reopening actually does to crypto
Crypto.News Published 15.06.2026 08:57
-
Market Highlights: SpaceX Surges 55%, Qualcomm Rallies on AI Push, Dave & Buster’s Tumbles
Blocknomi Published 16.06.2026 12:20